Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Recruiting · NCT07011810 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Axatilimab for Sclerotic Chronic Graft-versus-Host Disease | Bronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-09-24 | NCT07011810 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fred Hutchinson Cancer Center | 123 |
| Incyte Corporation | 153 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 68 |
| Fred Hutch/University of Washington Cancer Consortium | Seattle | United States | 140 |
| Moffitt Cancer Center | Tampa | United States | 523 |